Related by context. All words. (Click for frequent words.) 68 cytoprotective 67 immunomodulatory 66 immunosuppressant 66 alkylating agent 66 selective inhibition 64 potent anticancer 64 proteasome inhibitors 64 antiproliferative 63 antiangiogenic 63 immune modulator 63 receptor inhibitor 63 Gleevec resistant 63 pro angiogenic 63 antitumor 63 angiogenesis inhibitor 63 mTOR inhibitors 63 anti angiogenic 63 EGFr 63 proteasome inhibitor 63 VAPRISOL 63 immune modulating 63 anti secretory 63 antifibrotic 63 immune modulators 63 erythropoietic 63 tyrosine kinase inhibitor 62 IFN alpha 62 hedgehog pathway 62 immune suppressing 62 idarubicin 62 cytotoxic 62 Pathway Inhibitor 62 calcineurin inhibitors 62 anti proliferative 62 neurotrophic 62 VEGF inhibitors 62 immunomodulator 62 anticlotting 62 vascular disrupting agents 62 immune suppression 62 Symadex 62 pharmacokinetic interactions 61 MEK inhibitors 61 antiinflammatory 61 ALK inhibitor 61 Bortezomib 61 Dasatinib 61 histone deacetylase HDAC inhibitors 61 tyrosine kinase inhibitors 61 enzyme inhibitor 61 TNFa 61 orally bioavailable 61 selective inhibitor 61 CCR2 61 molecularly targeted 61 microtubule inhibitor 61 anticancer agent 61 Cyclosporine 61 vinca alkaloid 61 nucleoside analog 61 fibrinolytic 61 sCD# 61 protease inhibitor 61 imatinib Gleevec ® 61 glucocorticoid 61 bleomycin 61 LHRH agonists 61 EGFR inhibitors 61 IAP inhibitor 61 synthetic peptide 61 beta adrenergic 61 immunosuppressant drug 61 immunosuppressive drugs 61 receptor antagonists 61 Talabostat 61 bortezomib Velcade 61 echinocandins 61 oral prodrug 61 PEGylated 61 anticancer 61 chemopreventive agent 61 olmesartan 61 enzyme inhibitors 60 Cyclosporin 60 interferons 60 itraconazole 60 acadesine 60 HDACi 60 decitabine 60 liposomal formulation 60 cidofovir 60 anti angiogenic drugs 60 estrogen receptor beta 60 JAK3 60 interferon IFN 60 immune suppressive 60 chemotherapeutics 60 mycophenolate mofetil 60 Interferon alpha 60 milatuzumab 60 amphotericin B 60 deacetylase inhibitors 60 TNF α 60 immunomodulators 60 lapatinib Tykerb 60 antitumoral 60 dasatinib Sprycel 60 hypoxia inducible factor 60 potent antiproliferative 60 VDAs 60 VA# [002] 60 novel immunomodulatory 60 CCR5 antagonist 60 selective modulator 60 immunosuppression 60 immunomodulatory effects 60 tumorigenic 60 protease inhibitors 60 cyclosporin 60 imatinib resistant 60 uric acid lowering 60 activin 60 fulvestrant 60 alefacept 60 erlotinib Tarceva 60 oral antiviral 60 sorafenib Nexavar 60 antithrombotic 60 receptor agonists 60 Protease inhibitors 60 microtubule targeting 60 thalidomide Thalomid 60 Vidofludimus 60 CYP #A# 60 mTOR inhibitor 60 endothelin receptor 60 #ME# 60 SERMs 60 sodium glucose cotransporter 60 integrase inhibitor 59 chemotherapeutic agents 59 anticancer therapy 59 gemcitabine Gemzar 59 isoproterenol 59 Trastuzumab 59 inducible nitric oxide synthase 59 pomalidomide 59 CYC# 59 gamma secretase inhibitor 59 PI3K inhibitor 59 signal transduction inhibitor 59 cytostatic 59 Imatinib 59 potent cytotoxic 59 LPA1 receptor 59 interferon beta 59 multitargeted 59 taxol 59 incretin 59 immunomodulating 59 Vorinostat 59 CDDO Im 59 HDAC 59 antidiabetic 59 nephrotoxicity 59 DFMO 59 azacytidine 59 nucleoside analogues 59 immunotoxins 59 imatinib resistance 59 chemotherapeutic agent 59 immunosuppressive agents 59 Vaprisol 59 systemically administered 59 immune modulation 59 cyclooxygenase 59 AMN# [001] 59 insulin sensitizing 59 orally dosed 59 immuno suppressive 59 leukemic stem cells 59 glucocorticoids 59 immunosuppressants 59 taxanes 59 antiarrhythmic 59 anti mitotic 59 vWF 59 aprepitant 59 pro apoptotic 59 nucleoside analogs 59 factor TNF 59 JAK inhibitors 59 nucleoside 59 Cisplatin 59 Th2 cells 59 immune stimulatory 59 pDCs 59 endothelin receptor antagonists 59 chemotherapeutic drugs 59 anti neoplastic 59 peptidic 59 quinolone 59 Factor VIIa 59 peptide antigens 59 drug ISA# 59 p# inhibitors 59 erlotinib Tarceva ® 59 vasodilatory 59 HDAC inhibitors 59 lenalidomide Revlimid R 59 potent neuroprotective 59 ADP receptor antagonist 59 menadione 59 imatinib Gleevec 59 NF kB pathway 59 receptor blocker 59 anti leukemic 59 EGF receptor 59 TYZEKA 59 GHRH 59 Xanafide 59 immunosuppressive therapies 59 pharmacologic 59 5 HT2A inverse 59 anti androgen 59 metaglidasen 59 trastuzumab Herceptin ® 59 HuLuc# 58 BAY #-# 58 Everolimus 58 raltegravir 58 anti angiogenic agents 58 substrates inhibitors 58 Lixivaptan 58 pegfilgrastim 58 tubulin binding 58 anticancer treatments 58 Vidaza azacitidine 58 anti fibrotic 58 apoptotic pathway 58 Maribavir 58 Tumor Necrosis Factor 58 HCV protease inhibitors 58 receptor tyrosine kinase inhibitor 58 CTLA 4 58 IL 1ß 58 bradykinin 58 YONDELIS 58 favorable pharmacokinetic 58 Dapagliflozin 58 Rituximab 58 histone deacetylase inhibitor 58 G CSF 58 vascular disrupting agent 58 selectively inhibit 58 selective inhibitors 58 muscarinic 58 insulin sensitizers 58 vorinostat 58 BAL# [001] 58 protamine 58 multidrug resistance 58 adrenal hormone 58 histone deacetylase inhibitors 58 antiangiogenic agent 58 xanthine oxidase inhibitor 58 antiapoptotic 58 immune modulatory 58 ischemia reperfusion injury 58 immunosuppressive regimen 58 Squalamine 58 visilizumab 58 potent anti angiogenic 58 trastuzumab Herceptin 58 cyclopamine 58 Sym# 58 pegylated 58 Blinatumomab 58 peptibody 58 etoposide 58 IAP inhibitors 58 Gefitinib 58 partial agonist 58 dexamethasone Decadron 58 PDE4 inhibitors 58 HCV replication 58 gamma secretase inhibitors 58 prostaglandin synthesis 58 TriRima 58 potentially hepatotoxic 58 JAK2 enzyme 58 kinase inhibitors 58 thrombin receptor 58 haematopoietic 58 ENMD # 58 beta agonists 58 prostaglandin D2 58 inhibits protein synthesis 58 Skp2 58 small molecule Hedgehog 58 antimetastatic 58 TGF beta 58 tafamidis 58 trabectedin 58 HSP# inhibitor 58 riociguat 58 interferon 58 TRV# [001] 58 thyroid hormone receptor 58 GnRH agonists 58 PARP inhibitors 58 histone deacetylase HDAC 58 rifamycin 58 azacitidine 58 mapatumumab 58 peripherally acting 58 thrombopoietin 58 blood clot dissolving 58 selective antagonist 58 SGLT2 58 panitumumab Vectibix 58 relapsed leukemia 58 antiproliferative effects 58 immunotoxin 58 angiogenesis inhibitors 58 GPIIb IIIa 58 antimetabolite 58 CGRP 58 Aldosterone 58 JAK1 58 anti VEGF 58 chemotherapeutic drug 58 intravenous bisphosphonates 58 mTOR mammalian target 58 Cytoxan 58 antitumor effect 58 Temsirolimus 58 vitamin D analogs 58 MMP inhibitors 58 rifamycins 58 NF kappaB activation 58 imatinib 58 anti thrombotic 58 small molecule inhibitors 58 Aviptadil 58 induce apoptosis 58 Valproic acid 58 interleukins 58 small molecule tyrosine 58 posaconazole 58 renal toxicity 58 histone deacetylase HDAC inhibitor 58 P#X# 58 novel peptide 58 orally administered inhibitor 58 HMG CoA reductase inhibitors 57 Noxafil 57 osteoblast 57 beta lactam antibiotic 57 renoprotective 57 angiotensin receptor blocker ARB 57 polymerase inhibitors 57 mutated KRAS 57 neuro protective 57 Angiotensin II 57 flavopiridol 57 anticancer activity 57 Aurora Kinase 57 ISTODAX 57 antiemetics 57 pleiotropic 57 PDGF receptor 57 nonsteroidal 57 immunostimulatory 57 angiotensin receptor 57 XYOTAX TM 57 cardiotoxic 57 Temozolomide 57 CA4P 57 topical antifungal 57 octreotide 57 intravesical 57 antiangiogenesis 57 L dopa 57 Src inhibitors 57 CEQ# 57 anticancer agents 57 mecamylamine 57 GM CSF 57 gonadotropin releasing hormone 57 oxybutynin 57 HuMax CD4 57 nicotinic acid 57 Hsp# inhibitors 57 heparanase 57 Panzem 57 factor G CSF 57 endostatin 57 nilotinib Tasigna ® 57 CCL# 57 neutralizing antibody 57 NRTIs 57 Bezielle 57 tolerogenic 57 panobinostat 57 myeloablative 57 lupus nephritis 57 topoisomerase 57 Elacytarabine 57 apoptosis induced 57 cilengitide 57 Tolvaptan 57 somatostatin analogue 57 selective estrogen receptor 57 IFN beta 57 anticancer therapies 57 chemoresistance 57 TLR9 agonist 57 oral antifungal 57 investigational humanized monoclonal antibody 57 GRK2 57 sphingosine 1 57 Th2 cytokines 57 ENaC 57 camptothecin 57 PPARγ 57 angiotensin 57 Velcade bortezomib 57 potent antiviral 57 trans retinoic acid 57 alkylating agents 57 inhibitory effects 57 retinoid 57 VEGF receptors 57 corticosteroid therapy 57 adalimumab Humira 57 dasatinib Sprycel ® 57 alagebrium 57 NFkappaB 57 anti TNF 57 rapamycin 57 Crizotinib 57 potent inhibitors 57 anticholinergic 57 chemotherapies 57 calcitriol 57 immunomodulation 57 vinblastine 57 intravenous cyclophosphamide 57 Anticholinergic 57 recurrent glioblastoma multiforme 57 dosing frequency 57 talabostat 57 pertuzumab 57 hematopoietic cells 57 BRAF kinase 57 anti muscarinic 57 effector function 57 prodrug 57 FK# 57 vinorelbine 57 Sugammadex 57 serotonin reuptake 57 Panzem R 57 potent inhibitory 57 interferon alpha 57 depsipeptide 57 CTGF 57 Bevacizumab 57 glucose lowering 57 levodopa carbidopa 57 superficial bladder cancer 57 Notch1 57 transient receptor 57 anti resorptive 57 protease inhibitor PI 57 PNP inhibitor 57 neurogenic 57 Epothilones 57 serotonin receptor 57 INCB# [001] 57 IGFBP 3 57 TNF inhibitor 57 PSN# [002] 57 mimetics 57 mAbs 57 TREANDA 57 TNF inhibitors 57 Treg cell 57 docetaxel Taxotere ® 57 drug zotarolimus 57 telomerase activator 57 p# MAP kinase 57 REP# 57 targeted antifolate 57 Alocrest 57 glucagon receptor 57 Hedgehog pathway 57 glucocorticoid receptor 57 NMDA antagonist 57 granisetron 57 NNRTIs 57 vasodilators 57 efalizumab 57 androgen receptors 57 Cloretazine 57 mesenchymal cell 57 HCV protease 57 NKT cells 57 humanized anti 57 elastase 57 cytotoxic T 57 PGE2 57 VEGF receptor 57 alpha blocker 57 small molecule activators 57 lung fibrosis 57 osteogenic 57 RAS blockers 57 Arranon 57 TLR8 57 lenalidomide dexamethasone 57 Bcr Abl mutations 57 Epratuzumab 57 Anidulafungin 57 antimitotic 57 Doxil ® 57 L asparaginase 57 azoles 57 HDAC inhibition 57 rolipram 57 busulfan 57 Interferon alfa 57 Bcl xL 57 Pertuzumab 57 vincristine 57 PI3K/mTOR 57 BiTE 57 dihydrofolate reductase 57 paclitaxel Taxol 57 myelosuppression 57 humanized antibody 57 FVIII 57 gemcitabine Gemzar ® 57 Lodamin 57 leukotriene 57 receptor monoclonal antibody 57 OXi# 57 doxorubicin 57 eltrombopag 57 bortezomib 57 reperfusion injury 57 Traficet EN 57 ixabepilone 57 miglustat 57 inhibit tumor 57 allogeneic HSCT 57 alkylating 57 pamidronate 57 factor Xa 57 anti inflammatory 57 IRX 2 57 bevacizumab Avastin 57 bexarotene 57 nitric oxide synthase 56 parathyroid hormone PTH 56 nucleosides 56 adenosine receptor 56 immuno modulatory 56 Immunosuppressive 56 MGCD# [001] 56 macrolide antibiotics 56 somatostatin analogs 56 chitinase 56 TACE 56 phosphate binding 56 trans retinoic acid ATRA 56 IGF1R 56 TNF therapy 56 Gleevec imatinib 56 PTHrP 56 C5aR 56 targeted radiotherapeutic 56 adrenergic 56 TGF ß 56 eNOS 56 Rasagiline 56 laropiprant 56 PRT# 56 cytokine signaling 56 Talactoferrin 56 receptor subtype 56 CsA 56 T#I mutant 56 seliciclib 56 antitumour 56 anti CD3 56 myelofibrosis polycythemia vera 56 Tacrolimus 56 receptor antagonist 56 gonadotropin releasing hormone GnRH 56 nephrotoxic 56 interferon pathway 56 daptomycin 56 Orally administered 56 IKK2 56 rhIL 7 56 VEGF 56 chemotherapeutic 56 IGF IR 56 Zolinza 56 immunoregulatory 56 TNFα 56 Doxorubicin 56 targeting CD# 56 ganetespib 56 Voreloxin 56 nicotinic acetylcholine receptor 56 #beta HSD1 56 inhibit angiogenesis 56 novel anticancer 56 cyclophosphamide 56 IFN gamma 56 immunomodulatory properties 56 B7 H1 56 Tasimelteon 56 p# activation 56 epothilone 56 anti CD3 antibody 56 IMiDs ® 56 recombinant enzyme 56 TLR8 agonist 56 alpha interferon 56 biologic therapy 56 OHR/AVR# 56 Valortim R 56 cytotoxicity 56 MTP inhibitor 56 kinase inhibitor 56 adriamycin 56 renin inhibitors 56 PI3 kinase 56 nelfinavir 56 forskolin 56 systemic antifungal 56 virotherapy 56 meropenem 56 AChE inhibitor 56 PEGylated Fab fragment 56 PORxin TM 56 PKC# 56 favorable pharmacokinetic profile 56 cyclin dependent kinase inhibitor 56 non nucleoside 56 pegylated liposomal doxorubicin 56 gastrin 56 histone deacetylases 56 factor Xa inhibitor 56 lipoglycopeptide 56 PDGFR 56 CTLA4 Ig 56 taxane chemotherapy 56 adenosine A2A 56 veltuzumab 56 Cellcept 56 immune suppressants 56 Nonsteroidal anti inflammatory 56 beta lactam 56 nucleotide analogue 56 antiepileptic 56 ganciclovir 56 NEUGENE 56 neuroprotective properties 56 FOLFOX chemotherapy 56 Elvitegravir 56 RDEA# 56 gastrointestinal stromal tumors GIST 56 PI3K 56 N methyl 56 intravenously administered 56 WT1 56 Amplimexon 56 radioprotective 56 cetuximab Erbitux ® 56 pan HDAC inhibitor 56 antibody mediated 56 PPAR γ 56 plasmin 56 Aliskiren 56 Taxol paclitaxel 56 allogeneic stem cell 56 activate p# 56 protein kinase inhibitor 56 LHRH agonist 56 endoxifen 56 imetelstat 56 inhibit replication 56 TRO# 56 Preclinical studies suggest 56 Receptor Antagonists 56 GRN#L 56 LEP ETU 56 Gemzar gemcitabine 56 anti angiogenic agent 56 LMWHs 56 anti atherogenic 56 liposomal 56 highly immunogenic 56 Vascugel 56 TKIs 56 resolvins 56 TAT2 56 antifungal drugs 56 administered subcutaneously 56 MGd 56 nanoviricide 56 sorafenib tablets 56 replicon 56 Archexin 56 uricase 56 calcineurin 56 bevacizumab Avastin ® 56 small molecule inhibitor 56 pegylated interferons 56 Chronic Myeloid Leukemia CML 56 antiresorptive 56 OMP #R# 56 anti anginal 56 antifungal therapy 56 bronchodilatory 56 CBLC# 56 PEG SN# 56 adefovir 56 Onconase 56 cardiac toxicity 56 XmAb# 56 adeno associated viruses 56 Nanobody 56 lymphotoxin 56 CHOP chemotherapy 56 NEUGENE antisense 56 Inosine 56 tumor vascular disrupting 56 relapsed ovarian cancer 56 anthracyclines 56 chimeric monoclonal antibody 56 Lenalidomide 56 atacicept 56 cytotoxic chemotherapy 56 CD# antibody [001] 56 fusion inhibitors 56 histone deacetylase 56 durable remissions 56 sulindac 56 otelixizumab 56 anti angiogenesis 56 CCR5 inhibitor 56 Maraviroc 56 demethylating agents 56 oral anticancer 56 relapsing remitting multiple sclerosis 56 tyrosine kinase inhibitors TKIs 56 Melphalan 56 adipogenic 56 amikacin 56 remyelination 56 HSP# inhibitors 56 neuroprotectant 56 Sudhir Agrawal D.Phil 56 tigecycline 56 NPD1 56 HER2 receptor 56 nucleoside analogue 56 Triapine R 56 B vitamin niacin 56 EGFR signaling 56 γ secretase 56 Eltrombopag 56 oxaliplatin Eloxatin 56 PARP inhibitor 56 IL 1β 56 Mipomersen 56 mitochondrial toxicity 56 myopathy rhabdomyolysis 56 FLT3 56 BRAF inhibitors 56 tipifarnib 56 Bendamustine 56 heavily pretreated 56 synthetic retinoid 56 IMiDs R 56 basiliximab 56 prodrugs 56 GW# [003] 56 prokinetic 56 TNF blocking 56 tumor vasculature 56 antiangiogenic agents 56 angiotensin II receptor 56 protein mTOR 56 pemetrexed Alimta 56 androgen receptor AR 56 angiotensin II receptor blocker 56 MYLOTARG 56 gemcitabine 56 Pegylated 56 Corticosteroids 56 B7 H3 56 Neulasta ® 56 NXL# 56 HQK 56 TELINTRA 56 ISIS # 56 EGFR TKIs 56 polyketides 56 CB2 receptor 56 ligand TRAIL 56 K ras mutations 56 beta lactams 56 valproic acid 56 neutralizing antibodies 56 TB4 56 Teriflunomide 56 antirheumatic 56 immunogenic 56 Smac mimetics 56 SIRT2 56 potently inhibit 56 hepatotoxic 56 potassium sparing diuretics 56 TrkA 56 monoclonal antibody therapies 56 retinoids 56 radiosensitivity 56 imatinib therapy 56 HAART regimen 56 antifungal agent 56 caspofungin 56 nucleoside reverse transcriptase inhibitors 56 Akt activation 56 FGFR1 56 5 HT2A receptor 56 Interferon beta 55 CCR9 55 interferon lambda 55 LY# [003] 55 CDK inhibitor 55 CG# [003] 55 humanized monoclonal antibody 55 M1 muscarinic 55 C5a 55 tyrosine kinase inhibitor TKI 55 anti CD# antibody 55 retinoic acid 55 anti inflammatory cytokine 55 immunomodulatory therapy 55 MAXY G# 55 Raltegravir 55 prostanoid 55 Treg cells 55 benzimidazole 55 chemopreventive 55 CYT# potent vascular disrupting 55 disease modifying 55 elvitegravir 55 metastatic RCC 55 mitoxantrone 55 Anti angiogenic 55 Chemophase 55 hematopoietic 55 EGFR tyrosine kinase inhibitors 55 peroxisome proliferator activated 55 tubulin polymerization 55 endothelin 55 immunosuppressant drugs 55 gastrointestinal motility 55 Arimoclomol 55 HGS ETR2 55 eotaxin 55 55 Hedgehog signaling 55 antineoplastic 55 polymerase inhibitor 55 AT1R 55 BZL# 55 adult mesenchymal stem 55 antisense oligonucleotides 55 costimulation 55 tumorigenicity 55 rifalazil 55 ERK signaling 55 lipid lowering therapies 55 ADAM# 55 AAV2 55 ErbB 55 immunological 55 selective HDAC inhibitors 55 TKI therapy 55 Carfilzomib 55 tricyclic 55 Taxol ® 55 PSN# [001] 55 RANK Ligand 55 CCR5 antagonists 55 NS4A 55 mitogenic 55 adhesion molecule 55 Pioglitazone 55 systemic immunosuppressive 55 NKG2D 55 Herceptin trastuzumab 55 COX2 55 Erlotinib 55 inflammatory cytokines 55 pyrimidines 55 vidofludimus 55 PXD# 55 TGF β 55 bryostatin 55 TRIOLEX 55 luteinizing hormone releasing 55 Mitoxantrone 55 asparaginase 55 PDE5 55 Aflibercept 55 Cethrin R 55 Aplidin 55 prostaglandin E2 55 Personalized Immunotherapy 55 corticosteroid dexamethasone 55 palifermin 55 HIF1 55 SCCHN 55 myeloid derived 55 glucocorticoid receptors 55 indomethacin 55 methylnaltrexone 55 protease inhibitors PIs 55 multikinase inhibitor 55 PDE# 55 5 HT6 receptor 55 hypotensive 55 PI3K delta 55 CXCL# 55 topoisomerase II inhibitor 55 oral JAK1 55 xenograft models 55 therapeutic monoclonal antibody 55 protein kinase inhibitors 55 interferon gamma 55 infused intravenously 55 5 lipoxygenase 55 phosphate S1P 55 lysophosphatidic acid 55 PPAR alpha 55 acute GvHD 55 PPAR gamma agonist 55 acetylcholinesterase 55 Vincristine 55 cyclophosphamide Cytoxan 55 IMiDs ® compound 55 thiazolidinedione TZD 55 taxane 55 CD# monoclonal antibody 55 novel VDA molecule 55 SGS# 55 fibrotic disease 55 Enzastaurin 55 triphendiol 55 pyrazinamide 55 cytotoxic effects 55 indibulin 55 potent antitumor 55 androgen hormone 55 Axitinib 55 Tarvacin 55 IV bisphosphonates 55 promising anticancer 55 small molecule 55 Taxotere docetaxel 55 AMD# [003] 55 temsirolimus 55 nucleotide analogs 55 oncolytic 55 mucosal immunity 55 proliferator activated receptor 55 DHFR 55 IFNs 55 belatacept 55 receptor activation 55 interferon alfa 55 cediranib 55 CXCR2 55 Luteinizing Hormone Releasing Hormone 55 Telmisartan 55 Seliciclib 55 induces apoptosis 55 angiotensin II 55 Anthracycline